Independent pharmacies' share rises to 43.8%; YSB (09885) increases supply of high-margin categories.
According to the interim report previously disclosed by YSB, high-margin categories have become the main source of its profit growth.
According to recent industry data for the first half of the year released by Menet, the number of retail pharmacies nationwide has fallen from a peak of 706,000 to 665,000, a decrease of about 41,000; in the first half, average monthly sales per store were RMB82,000, up only 2% year on year, with order volume up 5% and average ticket size down 3%. The number of pharmacies is shrinking, and they are still facing survival challenges. In addition, according to National Medical Products Administration data, by the end of 2025 the number of independent stores nationwide had grown to 287,300, accounting for 43.8%. Some analysts believe that how to help independent pharmacies improve efficiency may be key for YSB (09885) as it seeks a new growth curve.
Since the beginning of this year, pharmacy retail terminals have shown three characteristics: the total number of stores is declining, the share of independent stores is rising, and the customer base has not shrunk along with the industry; for independent stores to improve efficiency, private labels and externally sourced categories have become essential; and medical insurance designated status is shifting to a quota system, making compliance capability shift from a bonus item to an admission requirement. The combined result of these three is that the harder independent pharmacies find things, the deeper their need for external supply and service efficiency improvements.
YSB's upstream is brands and private labels, and its downstream is hundreds of thousands of grassroots pharmacies and clinics, connected in the middle by two channels: self-operated and platform; tools such as Zhangdianyi and Guangpu extend services from drug transactions to store operations. This enables it to provide two types of supply at the same time: high-margin categories that independent pharmacies cannot obtain on their own, and compliance capabilities that they cannot build themselves.
YSB's previously disclosed interim results show that high-margin categories have become its main source of profit growth. First-half revenue was RMB10.283 billion, up 4.5% year on year; the transaction scale of private labels and brand first-push products grew 30.4% and 18.6%, respectively, and the self-operated gross margin rose from 7.7% to 8.3%; net profit attributable to shareholders was RMB111 million, up 41.9%. Since the third quarter, the first-push business has continued its good development momentum, especially among grassroots medical institution customers, with both order numbers and paying users achieving growth.
From a valuation perspective, this round of improvement has not yet been fully reflected in the share price. Based on a rough conversion using the closing price on November 16, the company's market value is about HK$2.3 billion; based on 2025 net profit attributable to shareholders of RMB153 million, the corresponding price-to-earnings ratio is about 14 times. The digital penetration rate of out-of-hospital pharmaceuticals remains low, demand from grassroots terminals for high-margin categories and compliance capabilities is rising in tandem, the supply advantage of platform and self-operated collaboration is expected to become more evident, and room for medium- to long-term value re-rating may gradually open up.
Related Articles

Anthropic's passive buying after listing could exceed US$19 billion: but its index inclusion may lag several steps behind SpaceX (SPCX.US)

Apple Inc. (AAPL.US) Introduces Face Unlock for iPhone Duo, Closing a Key User Experience Gap

CITIC SEC: New-type energy storage "15th Five-Year Plan" introduced; returns on generation-side storage deployment expected to improve.
Anthropic's passive buying after listing could exceed US$19 billion: but its index inclusion may lag several steps behind SpaceX (SPCX.US)

Apple Inc. (AAPL.US) Introduces Face Unlock for iPhone Duo, Closing a Key User Experience Gap

CITIC SEC: New-type energy storage "15th Five-Year Plan" introduced; returns on generation-side storage deployment expected to improve.






